
Releases
Immutep Investors Face Class Action Over Alleged Trial Misrepresentations
The Schall Law Firm is rallying investors who purchased Immutep Limited securities between March 24, 2025, and March 12, 2026, to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centering on claims that the company misled shareholders regarding the efficacy of its TACTI-004 trial.





















